| Structure |
Chemical Name |
CAS |
MF |
 |
1H-Imidazol-5-amine,1-methyl-4-nitro-(9CI) |
4531-54-8 |
C4H6N4O2 |
 |
4-Nitro-2-phenoxyaniline |
5422-92-4 |
C12H10N2O3 |
 |
GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE) |
119018-30-3 |
C18H23N3O6S |
 |
N-Succinyl-L-tyrosine |
374816-32-7 |
C13H15NO6 |
![2-Naphthacencarboxamid, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochlorid, [4S-(4α,4aα,5α,5aα,6β,12aα)]-](/CAS/GIF/41411-66-9.gif) |
2-Naphthacencarboxamid, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochlorid, [4S-(4α,4aα,5α,5aα,6β,12aα)]- |
41411-66-9 |
C22H25ClN2O8 |
![[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop](/CAS/20150408/GIF/99742-35-5.gif) |
[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop |
99742-35-5 |
C23H38N2O5 |
 |
HYOSCINE BUTYLBROMIDE IMPURITY E |
|
|
|
|
BUPIVACAINE IMPURITY B |
|
|
 |
Proguanil Related Compound C (25 mg) (1,5-bis(4-chlorophenyl)biguanide hydrochloride) |
13590-98-2 |
C14H14Cl3N5 |
 |
GLUCOSAMINE SULFATE SODIUM CHLORIDE |
1296149-13-7 |
C6H15ClNNaO9S |
 |
Clazuril |
101831-36-1 |
C17H10Cl2N4O2 |
![Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride)](/CAS/20180808/GIF/61709-33-9.gif) |
Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride) |
61709-33-9 |
C16H15Cl3N2OS |
![Propafenone Related Compound B ((2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one)](/CAS/20180808/GIF/88308-22-9.gif) |
Propafenone Related Compound B ((2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one) |
88308-22-9 |
C21H25NO3 |
 |
ERYTHROMYCIN B |
527-75-3 |
C37H67NO12 |
 |
1-Cyano-3-isopropylguanidine |
44830-55-9 |
C5H10N4 |
 |
(R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE |
103765-01-1 |
C8H14N2O2 |
 |
4'-(Pyrimidin-2-ylsulfamoyl)acetanilid |
127-74-2 |
C12H12N4O3S |
|
|
OXALIPLATIN IMPURITY D |
|
|
 |
LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE) |
6538-82-5 |
C7H13ClNO2 |
![octahydro-2-nitrosocyclopenta[c]pyrrole](/CAS/GIF/54786-86-6.gif) |
octahydro-2-nitrosocyclopenta[c]pyrrole |
54786-86-6 |
C7H12N2O |
 |
LevetiracetaM IMpurity B |
358629-47-7 |
C8H12N2O2 |
 |
Loratadine EP IMpurity F |
125743-80-8 |
C22H24ClFN2O2 |
 |
INSULIN LISPRO (5.97 MG) |
133107-64-9 |
C257H383N65O77S6 |
 |
TRAMADOL IMPURITY E |
|
C16H25NO2 |
 |
FLUCONAZOLE IMPURITY B |
|
C13H12F2N6O |
|
|
Fosinopril Related Compound B |
|
|
![1-[(2S)-3-BroMo-2-Methyl-1-oxopropyl]-L-proline](/CAS/GIF/80629-35-2.gif) |
1-[(2S)-3-BroMo-2-Methyl-1-oxopropyl]-L-proline |
80629-35-2 |
C9H14BrNO3 |
 |
N-Des(cyclohexylaMinocarbonyl) Glipizide |
1346600-54-1 |
C14H16N4O3S |
 |
Estra-1,3,5(10)-trien-3,17β-diol-17-butyrat |
18069-79-9 |
C22H30O3 |
 |
Citalopram Related Compound H (25 mg) (1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide) |
479065-02-6 |
C19H22Br2FNO |
![2-[(1,1-DIMETHYLETHYL) AMINO]-1-[4-OH-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE](/CAS/GIF/156547-62-5.gif) |
2-[(1,1-DIMETHYLETHYL) AMINO]-1-[4-OH-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE |
156547-62-5 |
C13H19NO3 |
|
|
INSULIN ASPART |
116094-23-6 |
C256H381N65O79S6 |
![1-(3,4-Dihydroxyphenyl)-2-[(1-methylethyl)amino]hydrochlorid](/CAS/GIF/16899-81-3.gif) |
1-(3,4-Dihydroxyphenyl)-2-[(1-methylethyl)amino]hydrochlorid |
16899-81-3 |
C11H15NO3.ClH |
 |
Talampicillin hydrochloride |
39878-70-1 |
C24H23N3O6S.ClH |
 |
Citalopram Related Compound B |
1332724-03-4 |
C22H23FN2O6 |
![[3-[2-(diMethylaMino)ethyl]-2-[[3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-1H-indol-5-yl]-N-MethylMethanesulfonaMide, succinate salt](/CAS/GIF/545338-89-4.gif) |
[3-[2-(diMethylaMino)ethyl]-2-[[3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-1H-indol-5-yl]-N-MethylMethanesulfonaMide, succinate salt |
545338-89-4 |
C27H37N5O2S |
 |
10-Formylfolic Acid |
134-05-4 |
C20H19N7O7 |
 |
Dextranomer |
56087-11-7 |
C41H68O30X4 |
 |
Platinum, (1,2-cyclohexanediamine-N,N')dinitrato-,(sp-4-2, 1R-trans)- |
66900-68-3 |
C6H12N4O6Pt |
 |
Propoxyphene Related Compound B (50 mg) (alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane) |
53990-51-5 |
C21H27NO2 |
 |
cis-Atovaquone |
137732-39-9 |
C22H19ClO3 |
|
|
Getreide, Mehl |
68525-86-0 |
|
![KETAMINE RELATED COMPOUND A (50 MG) (1 -[(2-CHLOROPHENYL)(METHYLIMINO)METHYL]CYLCOPENTA-NOL)](/CAS/GIF/6740-87-0.gif) |
KETAMINE RELATED COMPOUND A (50 MG) (1 -[(2-CHLOROPHENYL)(METHYLIMINO)METHYL]CYLCOPENTA-NOL) |
6740-87-0 |
C13H16ClNO |
 |
TICLOPIDINE IMPURITY F |
62019-75-4 |
C14H14ClNS |
 |
alpha-Methyl-4-biphenylacetic acid |
6341-72-6 |
C15H14O2 |
 |
Olopatadine N-Oxide |
203188-31-2 |
C21H23NO4 |
 |
INDINAVIR (100 MG)F0D3080.971MG/MG(AI) |
180683-37-8 |
C36H49N5O5 |
|
|
FENTICONAZOLE IMPURITY D |
|
|
 |
CEFACLOR, DELTA-3-ISOMER (30 MG) |
152575-13-8 |
C15H14ClN3O4S |
 |
(9Z,12Z)-Octadeca-9,12-diensure, Monoester mit Glycerin |
26545-74-4 |
C21H38O4 |
![D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-](/CAS/GIF/105816-06-6.gif) |
D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis- |
105816-06-6 |
C19H27NO3 |
 |
N-isopropyltropinium |
58005-18-8 |
C11H22BrNO |
 |
1-Methyl-2-(Methylthio)iMidazole |
14486-52-3 |
C5H8N2S |
 |
6α-Fluor-11β,21-dihydroxy-16α-methylpregna-1,4-dien-3,20-dion-21-pivalat |
29205-06-9 |
C27H37FO5 |
|
|
Magnesium-24Mg solution |
|
|
![4-[Methyl[(2-amino-4-hydroxypteridine)-6-ylmethyl]amino]benzoic acid](/CAS/GIF/5623-18-7.gif) |
4-[Methyl[(2-amino-4-hydroxypteridine)-6-ylmethyl]amino]benzoic acid |
5623-18-7 |
C15H14N6O3 |
 |
Duloxetine IMpurity A |
947686-09-1 |
C25H23NO3S |
|
|
MeloxicaM Related CoMpound D |
|
|
|
|
AMIODARONE IMPURITY D |
|
|
 |
DIPHENHYDRAMINE IMPURITY A |
|
C17H21NO |
|
|
Cefprozil Related CoMpound K |
|
|
|
|
IFOSFAMIDE - REFERENCE SPECTRUM |
|
|
|
|
Hemoglobin HbA0 (non-glycated) |
|
|
 |
SulfaMethoxazole N4-glucoside |
119691-75-7 |
C16H21N3O8S |
|
|
OXFENDAZOLE IMPURITY B |
|
|
|
|
CLOSANTEL SODIUM DIHYDRATE |
|
|
 |
Fosinopril Related Compound D |
1356353-41-7 |
C30H47NNaO7P |
|
|
EUROSOIL 4 |
|
|
 |
Zinc 67Zn solution (certified for isotope abundance ratio) |
|
Zn |
|
|
Human serum (high creatinine) |
|
|
 |
Fluticasone Propionate Resolution Mixture |
|
C28H35F3O6S |
 |
L-Cefadroxil |
144790-28-3 |
C16H17N3O5S |
|
|
Lithium carbonate-7Li |
|
7Li2CO3 |
 |
rac N-Desisopropyl-N-ethyl Acebutolol |
441019-91-6 |
C17H26N2O4 |
 |
Oxybutynin IMpurity C |
1199574-70-3 |
C21H29NO3 |
|
|
LaMivudine Resolution Mixture C |
|
|
|
|
DIPHENOXYLATE HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
 |
1-(3,4-Dichlorphenyl)-5-isopropylbiguanidmonohydrochlorid |
6001-93-0 |
C11H16Cl3N5 |
|
|
Oxymetazoline impurity A |
|
|
|
|
PANCREAS POWDER (PROTEASE) BRP |
|
|
|
|
OXFENDAZOLE WITH IMPURITY D |
|
|
|
|
GENOMIC DNA OF ESCHERICHIA COLI O157 (EDL 933) |
|
|
|
|
Fosinopril Related Compound E |
|
|
|
|
GMO Standard ERM-BF411, Maize Bt-176 |
|
|
|
|
SuMatriptan Succinate Related IMpurities |
|
|
 |
FOSCARNET IMPURITY B |
55920-24-6 |
C3H8NaO5P |
 |
Δ2-Cefuroxime Axetil |
123458-61-7 |
C20H22N4O10S |
|
|
Abacavir Related CoMpounds Mixture |
|
|
 |
Chloroquine Related CoMpound E |
5428-61-5 |
C18H26ClN3 |
|
|
Fosinopril Related CoMpound F |
|
|
|
|
Pyrantel Related CoMpound A |
|
|
|
|
FLUMAZENIL - REFERENCE SPECTRUM |
|
|
![(endo,anti)-(±)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octanbromid](/CAS/20210111/GIF/58073-59-9.gif) |
(endo,anti)-(±)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octanbromid |
58073-59-9 |
C20H30BrNO3 |
|
|
Vancomycin B with Monodechlorovancomycin |
|
|
 |
Zinc acexamate |
70020-71-2 |
C16H28N2O6Zn |
|
|
BUPIVACAINE IMPURITY E |
|
|
 |
Cefoperazone dihydrate |
113826-44-1 |
C25H29N9O9S2 |
 |
Iron-56Fe solution |
|
Fe |
|
|
HEPARIN LOW-MOLECULAR-MASS FOR CALIBRATION CRS |
|
|
|
|
OXYTOCIN/DESMOPRESSIN VALIDATION MIXTURE |
|
|